Cutaneous manifestations of COVID-19: ¿chance or causality?
DOI:
https://doi.org/10.21615/cesmedicina.34.COVID-19.7Keywords:
Coronavirus infections, Skin diseases, ToxicodermaAbstract
This narrative review describes the manifestations of SARS-CoV-2 in skin at all ages reported to date. The objective is to understand the clinical presentation and time of onset in the course of the disease, to increase the performance of diagnostic tests and improve the identification of asymptomatic patients. They are classified into five groups: directly or indirectly related to the virus, toxicoderma, contact dermatitis and pressure trauma. Until now it has not been verified whether these lesions are due to a direct manifestation of the virus or due to an immune, nonspecific reaction or the treatments used.
Downloads
References
Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 Abr 29]. Disponible en https://doi.org/10.1111/jdv.16387. [Epub ahead of print]
Madigan LM, Micheletti RG, Shinkai K. How dermatologists can learn and contribute at the leading edge of the COVID-19 Global Pandemic. JAMA Dermatol [Internet]. 2020 [citado 2020 Abr 29. Disponible en: https://doi.org/10.1001/jamadermatol.2020.1438. [Epub ahead of print]
Magro C, Mulvey JJ, Berlin D, Nuovo G, Salvatore S, Harp J, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res [Internet]. 2020 [citado 2020 Abr 29];S1931524420300700. Disponible en: https://doi.org/10.1016/j.trsl.2020.04.007. [Epub ahead of print]
Galván Casas, C., Català, A., Carretero Hernández, G., Rodríguez‐Jiménez, P., Fernández Nieto, D., Rodríguez‐Villa Lario, et al. Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol [Internet]. 2020 [citado 2020 Abr 29]. Disponible en : https://doi.org/10.1111/bjd.19163. [Epub ahead of print]
Hedou M, Carsuzaa F, Chary E, Hainaut E, Cazenave‐Roblot F, Masson Regnault M. Comment on “Cutaneous manifestations in COVID‐19: a first perspective ” by Recalcati S. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 Abr 30]. Disponible en: https://doi.org/10.1111/jdv.16519. [Epub ahead of print]
Mahé A, Birckel E, Krieger S, Merklen C, Bottlaender L. A distinctive skin rash associated with Coronavirus Disease 2019 ?. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 1]. Disponible en: https://doi.org/10.1111/jdv.16471. [Epub ahead of print]
Jimenez-Cauhe J, Ortega-Quijano D, Prieto-Barrios M, Moreno-Arrones OM, Fernandez-Nieto D. Reply to “COVID-19 can present with a rash and be mistaken for dengue”: Petechial rash in a patient with COVID-19 infection. J Am Acad Dermatol [Internet]. 2020 [citado 2020 Abr 30];S0190962220305569. Disponible en: https://doi.org/10.1016/j.jaad.2020.04.016. [Epub ahead of print]
Joob B, Wiwanitkit V. COVID-19 can present with a rash and be mistaken for dengue. J Am Acad Dermatol [Internet]. 2020 [citado 2020 May 2];82(5):e177. Disponible en: https://doi.org/10.1016/j.jaad.2020.03.036
Amatore F, Macagno N, Mailhe M, Demarez B, Gaudy‐Marqueste C, Grob J, et al. SARS‐CoV‐2 infection presenting as a febrile rash. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 2];16528. Disponible en: https://doi.org/10.1111/jdv.16528. [Epub ahead of print]
Gianotti R, Zerbi P, Dodiuk-Gad RP. Clinical and histopathological study of skin dermatoses in patients affected by COVID-19 infection in the Northern part of Italy. J Dermatol Sci [Internet]. 2020 [citado 2020 May 3];S0923181120301432. Disponible en: https://doi.org/10.1016/j.jdermsci.2020.04.007. [Epub ahead of print]
Zengarini C, Orioni G, Cascavilla A, Horna Solera C, Fulgaro C, Misciali C, et al. Histological pattern in Covid‐19 induced viral rash. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 4]. Disponible en: https://doi.org/10.1111/jdv.16569. [Epub ahead of print]
Ahouach B1, Harant S2, Ullmer A3, Martres P4, Bégon E1, Blum L1, Tess O5, Bachmeyer C6. Cutaneous lesions in a patient with COVID‐19 are they related. Br J Dermatol [Internet]. 2020 [citado 2020 May 4]; 19168. Disponible en: https://doi.org/10.1111/bjd.19168. [Epub ahead of print]
Su C-J, Lee C-H. Viral exanthem in COVID-19, a clinical enigma with biological significance. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 6]. Disponible en : https://doi.org/10.1111/jdv.16469. [Epub ahead of print]
Van Damme C, Berlingin E, Saussez S, Accaputo O. Acute urticaria with pyrexia as the first manifestations of a COVID‐19 infection. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 7]. Disponible en: https://doi.org/10.1111/jdv.16523. [Epub ahead of print]
Estébanez A, Pérez-Santiago L, Silva E, Guillen-Climent S, García-Vázquez A, Ramón MD. Cutaneous manifestations in COVID-19: a new contribution. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 8]. Disponible en: https://doi.org/10.1111/jdv.16474. [Epub ahead of print]
Ehsani AH, Nasimi M, Bigdelo Z. Pityriasis rosea as a cutaneous manifestation of COVID‐19 infection. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 8]. Disponible en: https://doi.org/10.1111/jdv.16579. [Epub ahead of print]
Genovese G, Colonna C, Marzano AV. Varicella‐like exanthem associated with COVID‐19 in an 8‐year‐old girl: A diagnostic clue? Pediatr Dermatol [Internet]. 2020 [citado 2020 May 8]. Disponible en: https://doi.org/10.1111/pde.14201. [Epub ahead of print]
Manalo IF, Smith MK, Cheeley J, Jacobs R. A dermatologic manifestation of COVID-19: Transient livedo reticularis. J Am Acad Dermatol [Internet]. 2020 [citado May 10]. Disponible en: https://doi.org/10.1016/j.jaad.2020.04.018. [Epub ahead of print]
Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020 Dec;9(1):687-690. doi: 10.1080/22221751.2020.1741327.
Alramthan A, Aldaraji W. A case of COVID‐19 presenting in clinical picture resembling chilblains disease. First report from the Middle East. Clin Exp Dermatol [Internet]. 2020 [citado 2020 May 10]. Disponible en: https://doi.org/10.1111/ced.14243. [Epub ahead of print]
Piccolo V, Neri I, Filippeschi C, Oranges T, Argenziano G, Battarra VC, et al. Chilblain‐like lesions during COVID‐19 epidemic: a preliminary study on 63 patients. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 10]. Disponible en: https://doi.org/10.1111/jdv.16526. [Epub ahead of print]
Colonna C, Monzani Na, Rocchi A, Gianotti R, Boggio F, Gelmetti C. Chilblains‐like lesions in children following suspected Covid‐19 infection. Pediatr Dermatol [Internet]. 2020 [citado 2020 May 11]. Disponible en: https://doi.org/10.1111/pde.14210. [Epub ahead of print]
Recalcati S, Barbagallo T, Frasin LA, Prestinari F, Cogliardi A, Provero MC, et al. Acral cutaneous lesions in the Time of COVID‐19. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 11]. Disponible en: https://doi.org/10.1111/jdv.16533. [Epub ahead of print]
Bouaziz J, Duong T, Jachiet M, Velter C, Lestang P, Cassius C, et al. Vascular skin symptoms in COVID‐19: a french observational study. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 11] Disponible en: https://doi.org/10.1111/jdv.16544. [Epub ahead of print]
Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D, Arana-Raja A, et al. Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak. J Am Acad Dermatol [Internet]. 2020 [citado 2020 May 11]; S0190-9622(20)30709-
X. Disponible en: https://doi.org/10.1016/j.jaad.2020.04.093. [Epub ahead of print]
López‐Robles J, de la Hera I, Pardo J, Martínez J, Cutillas‐Marco E. Chilblain‐like lesions: a case series of 41 patients during the COVID‐19 pandemic. Clin Exp Dermatol [Internet]. 2020 [citado 2020 May 12]. Disponible en: https://doi.org/10.1111/ced.14275. [Epub ahead of print]
Kolivras A, Dehavay F, Delplace D, Feoli F, Meiers I, Milone L, et al. Coronavirus (COVID-19) infection–induced chilblains: A case report with histopathologic findings. JAAD Case Rep [Internet]. 2020 [citado 2020 May 12]. Disponible en: https://doi.org/10.1016/j.jdcr.2020.04.011. [Epub ahead of print]
Jones VG, Mills M, Suarez D, Hogan CA, Yeh D, Segal JB, et al. COVID-19 and Kawasaki Disease: Novel Virus and Novel Case. Hosp Pediatr [Internet]. 2020 [citado 2020 May 27]; hpeds.2020-0123. Disponible en: https://doi.org/10.1542/hpeds.2020-0123. [Epub ahead of print]
Licciardi F, Pruccoli G, Denina M, Parodi E, Taglietto M, Rosati S, et al. SARS-CoV-2–Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children. Pediatrics [Internet]. 2020 [citado 2020 May 27];e20201711. Disponible en: https://doi.org/10.1542/peds.2020-1711. [Epub ahead of print]
Schroeder AR, Wilson KM, Ralston SL. COVID-19 and Kawasaki Disease: Finding the Signal in the Noise. Hosp Pediatr [Internet]. 2020 [citado 2020 May 27];hpeds.2020-000356. Disponible en: https://doi.org/10.1542/hpeds.2020-000356. [Epub ahead of print]
A Vanegas Ramirez 1, D Efe 1, M Fischer 1. Drug-induced vasculitis in a patient with COVID-19. J Eur Acad Dermatol Venereol [Internet]. 2020 [citado 2020 May 12]. Disponible en: https://doi.org/10.1111/jdv.16588. [Epub ahead of print]
Grandolfo, M., Romita, P., Bonamonte, D., Cazzato, G., Hansel, K., Stingeni, L., et al. Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight. Dermatologic Therapy [Internet]. 2020 [citado 2020 May 12]. Disponible en: https://doi.org/10.1111/dth.13499. [Epub ahead of print]
Schwartz RA1, Janniger CK1. Generalized pustular figurate erythema A newly delineated severe cutaneous drug reaction linked with hydroxychloroquine. Dermatol Ther [Internet]. 2020 [citado 2020 May 12]. Disponible en: https://doi.org/10.1111/dth.13380. [Epub ahead of print]
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 CES Medicina
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Derechos de reproducción (copyright)
Cada manuscrito se acompañará de una declaración en la que se especifique que los materiales son inéditos, que no han sido publicados anteriormente en formato impreso o electrónico y que no se presentarán a ningún otro medio antes de conocer la decisión de la revista. En todo caso, cualquier publicación anterior, sea en forma impresa o electrónica, deberá darse a conocer a la redacción por escrito.
Plagios, duplicaciones totales o parciales, traduccones del original a otro idioma son de responsabilidad exclusiva de los autores el envío.
Los autores adjuntarán una declaración firmada indicando que, si el manuscrito se acepta para su publicación, los derechos de reproducción son propiedad exclusiva de la Revista CES Medicina.
Se solicita a los autores que proporcionen la información completa acerca de cualquier beca o subvención recibida de una entidad comercial u otro grupo con intereses privados, u otro organismo, para costear parcial o totalmente el trabajo en que se basa el artículo.
Los autores tienen la responsabilidad de obtener los permisos necesarios para reproducir cualquier material protegido por derechos de reproducción. El manuscrito se acompañará de la carta original que otorgue ese permiso y en ella debe especificarse con exactitud el número del cuadro o figura o el texto exacto que se citará y cómo se usará, así como la referencia bibliográfica completa.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
